Evaluation of Use of Tacrolimus vs. Cyclosporine on CLAD Incidence and Allograft Survival in the ISHLT Registry

Purpose: The ScanCLAD study reported a lower incidence of CLAD with the use of once daily tacrolimus vs. twice daily cyclosporine. Using the ISHLT Registry data, we evaluated the hypothesis that tacrolimus would be superior to cyclosporine with regards to CLAD development in real world clinical practice.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , K. Walter, H. Hixson, E.A. Belloli, K.M. Chan, A.C. Chang, D.M. Lyu Source Type: research